Linda Huber uses her biochemistry background and patent experience to represent medical and academic institutions, private foundations and medical device and pharmaceutical companies in intellectual property matters.
I focus on prosecuting biotechnology and life sciences patents, counseling clients on their patent portfolios and prosecution strategies, conducting due diligence of patent portfolios in corporate transactions and patent license agreements and advising clients on patent related license provisions.
Particular areas I focus on include cancer therapeutics, gastrointestinal diseases, diagnostics, gene therapy, stem cells, inflammatory conditions, neurological diseases, and nutritional products.
Through my understanding of my clients’ needs and goals, I develop and implement strategies to strengthen, manage and expand their patent portfolios. I also help them understand the implications of licensing terms.
Even with the current jurisprudence on subject matter eligibility, I see that strong patent protection can still be achieved by covering the technology via different angles. Academic institutions and companies, having a strategic patent prosecution plan, should not be deterred from pursuing patent protection for their innovations.
U.S. Patent and Trademark Office
University of California, Los Angeles, B.S., Biochemistry
University of San Diego School of Law, J.D., cum laude
Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe